Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Resveratrol Exacerbates Both Autoimmune and Viral Models of Multiple Sclerosis.
Fumaric Acid Esters Stimulate Astrocytic VEGF Expression through HIF-1α and Nrf2.
Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis.
Primary progressive multiple sclerosis developing in the context of young onset Parkinson's disease.
Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis.
[Relevance of Magnet Resonance Tomography in the Diagnosis and Assessment of Course of Disease in Patients with Multiple Sclerosis].
Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice.
[Encephalopathy and neuromyelitis optica: the importance of recognising atypical symptoms].
Relationship between symptom change, relapse activity and disability progression in multiple sclerosis.
Short-Term Effect of BalanceWear Therapy on Mobility in Older Adults With Mobility Limitations.
Poor Sleep in Multiple Sclerosis Correlates with Beck Depression Inventory Values, but Not with Polysomnographic Data.
Brain cytokines and disease.
Chronic inflammatory demyelinating polyneuropathy in common variable immunodeficiency.
Another Case of PML with Gilenya Reported by Novartis
Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.
Immune Modulatory Mesenchymal Stem Cells Derived from Human Embryonic Stem Cells Through a Trophoblast-like Stage.
Comparison of Compliance And Discontinuation Rates Among Ms Patients Treated With Fingolimod and Other Disease-Modifying Therapies: A Canadian Retrospective Claims Analysis.
Role of executive functions in prospective memory in multiple sclerosis: Impact of the strength of cue-action association.
Metabolomics in multiple sclerosis.
Microglia, physiology and behavior: A brief commentary.
Childhood-onset multiple sclerosis: report of 82 patients from Isfahan, Iran.
Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes.
Preclinical Models of Multiple Sclerosis: Advantages and Limitations towards Better Therapies.
[Actual medical care situation and therapeutic needs in multiple sclerosis : Impact of the Pharmaceutical Market Restructuring Act (AMNOG)].
Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis.
Pages
« first
‹ previous
…
709
710
711
712
713
714
715
716
717
…
next ›
last »